Exabis Library
Welcome to the e-CCO Library!
P716: A 2-week course of Exclusive Enteral Nutrition followed by the Crohn Disease Exclusion Diet is effective for Induction and Maintenance of Remission in children with Crohn Disease; the DIETOMICS-CD trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P716: Beta-blocker use is associated with a higher relapse risk of inflammatory bowel disease – a Dutch retrospective cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P716: Current smoking trends in British IBD patients in the age of e-cigarettes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P716: Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P716: The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P717 Ustekinumab in Crohn’s disease: Real-world outcomes from the Sicilian Network for inflammatory bowel diseases (SN-IBD):–Preliminary results
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P717: Comparison of two different techniques to assess vedolizumab trough levels in adult patients with IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P717: Faecal Microbiota Transplant in Ulcerative Colitis (FMTUC) – A randomised clinical trial feasibility study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P717: Higher ulcerative colitis/Crohn's disease ratio in a central region of Argentina
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P717: The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P717: Use of tramadol versus traditional opioids and adverse outcomes of Inflammatory Bowel Diseases: a Danish nationwide cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P718 Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P718: A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P718: Characterization of microbiota and metabolomic profile in human colonic surgical resections of UC patients
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P718: Discrepancies between patients’ preferences and physicians’ preference perception for oral formulations: A real-life survey
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P718: Risk of tuberculosis in patients with inflammatory bowel disease receiving biologics using two interferon-γ release assays as monitoring
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P718: The epidemiology of IBD differs in South Asian migrants compared to Caucasians; results from a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P719: Determinants of tobacco consumption in the Swiss IBD cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P719: Does radiation to the pelvis portend worse ileal pouch outcomes? An international multi-institution collaborative study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM